Ultragenyx Pharmaceutical (RARE) Q4 2022 Earnings

2NovConfirmed
Q1 2022
Q2 2022
Q3 2022
Q4 2022
-3.5
-2.76
-2.02
-1.28

Details

Expected EPS
-2.35
Actual EPS
-3.5
Surprise EPS
-1.15
Surprise Percent
+48.94%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -3.5 per share for Q4 2022.

0 Comments

Share your thoughts